Literature DB >> 25853248

Correction: Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer.

.   

Abstract

Entities:  

Year:  2015        PMID: 25853248      PMCID: PMC4390372          DOI: 10.1371/journal.pone.0123844

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
There are errors in the names and affiliations for the fourth and fifth authors. The correct names and affiliations should appear as shown here: Christoph Q. Schmidt3, Andreas Wortmann4 3 Institute of Pharmacology of Natural Products & Clinical Pharmacology, Ulm University, Ulm, Germany 4 Tierforschungszentrum, Ulm University, Ulm, Germany The correct citation is: Lucas T, Benihoud K, Vigant F, Schmidt C, Wortmann A, Bachem MG, et al. (2015) Hexon Modification to Improve the Activity of Oncolytic Adenovirus Vectors against Neoplastic and Stromal Cells in Pancreatic Cancer. PLoS ONE 10(2): e0117254. doi:10.1371/journal.pone.0117254
  1 in total

1.  Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer.

Authors:  Tanja Lucas; Karim Benihoud; Frédéric Vigant; Christoph Q Schmidt; Christoph Q Andreas Schmidt; Andreas Wortmann; Max G Bachem; Thomas Simmet; Stefan Kochanek
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.